These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18457612)

  • 1. The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis.
    Scanzello CR; Moskowitz NK; Gibofsky A
    Curr Rheumatol Rep; 2008 Jan; 10(1):49-56. PubMed ID: 18457612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis.
    Scanzello CR; Moskowitz NK; Gibofsky A
    Curr Pain Headache Rep; 2007 Dec; 11(6):415-22. PubMed ID: 18173975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rofecoxib: a review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis.
    Matheson AJ; Figgitt DP
    Drugs; 2001; 61(6):833-65. PubMed ID: 11398914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (ibuprofen, diclofenac, and nabumetone).
    Reicin AS; Shapiro D; Sperling RS; Barr E; Yu Q
    Am J Cardiol; 2002 Jan; 89(2):204-9. PubMed ID: 11792343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
    Hochberg MC
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):4-14. PubMed ID: 12528069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of adverse renovascular experiences among osteoarthritis patients treated with rofecoxib and comparator non-selective non-steroidal anti-inflammatory agents.
    Gertz BJ; Krupa D; Bolognese JA; Sperling RS; Reicin A
    Curr Med Res Opin; 2002; 18(2):82-91. PubMed ID: 12017215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral non-steroidal anti-inflammatory drugs versus other oral analgesic agents for acute soft tissue injury.
    Jones P; Dalziel SR; Lamdin R; Miles-Chan JL; Frampton C
    Cochrane Database Syst Rev; 2015 Jul; (7):CD007789. PubMed ID: 26130144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WITHDRAWN: Analgesia and non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hip.
    Towheed TE; Hochberg MC; Shea BJ; Wells G
    Cochrane Database Syst Rev; 2007 Jul; (1):CD000517. PubMed ID: 17636642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GP and patient perspectives on treatment with non-steroidal anti-inflammatory drugs for the treatment of pain in osteoarthritis.
    Crichton B; Green M
    Curr Med Res Opin; 2002; 18(2):92-6. PubMed ID: 12017216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2 selective inhibitors in the treatment of osteoarthritis.
    Laine L; White WB; Rostom A; Hochberg M
    Semin Arthritis Rheum; 2008 Dec; 38(3):165-87. PubMed ID: 18177922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should osteoarthritis be treated with nonsteroidal anti-inflammatory drugs?
    Brandt KD
    Rheum Dis Clin North Am; 1993 Aug; 19(3):697-712. PubMed ID: 8210582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal anti-inflammatory drug gastropathy: new avenues for safety.
    Roth SH
    Clin Interv Aging; 2011; 6():125-31. PubMed ID: 21753867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit-risk assessment of rofecoxib in the treatment of osteoarthritis.
    Schmidt H; Woodcock BG; Geisslinger G
    Drug Saf; 2004; 27(3):185-96. PubMed ID: 14756580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should nonsteroidal anti-inflammatory drugs be used to treat osteoarthritis?
    Brandt KD
    Rheum Dis Clin North Am; 1993 Feb; 19(1):29-44. PubMed ID: 8356260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular adverse events by non-steroidal anti-inflammatory drugs: when the benefits outweigh the risks.
    Zingler G; Hermann B; Fischer T; Herdegen T
    Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1479-1492. PubMed ID: 27575590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results from a patient survey to assess gastrointestinal burden of non-steroidal anti-inflammatory drug therapy contrasted with a review of data from EVA to determine satisfaction with rofecoxib.
    Steinfeld S; Bjørke PA
    Rheumatology (Oxford); 2002 Apr; 41 Supp 1():23-7; discussion 35-42. PubMed ID: 12173277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical delivery of nonsteroidal anti-inflammatory drugs for osteoarthritis.
    Herndon CM
    J Pain Palliat Care Pharmacother; 2012; 26(1):18-23. PubMed ID: 22448937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NSAID dilemma: managing osteoarthritis in high-risk patients.
    Roth SH; Anderson S
    Phys Sportsmed; 2011 Sep; 39(3):62-74. PubMed ID: 22030942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in the treatment of osteoarthritis with NSAIDs.
    Argoff CE
    Curr Med Res Opin; 2011 Jul; 27(7):1315-27. PubMed ID: 21561395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative management of spinal osteoarthritis with glucosamine sulfate and chiropractic treatment.
    Gottlieb MS
    J Manipulative Physiol Ther; 1997; 20(6):400-14. PubMed ID: 9272473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.